Home Pyridines 1062368-24-4
1062368-24-4,MFCD17169988
Catalog No.:AA008TEI

1062368-24-4 | 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
95%
in stock  
$47.00   $33.00
- +
10mg
95%
in stock  
$86.00   $60.00
- +
50mg
95%
in stock  
$232.00   $163.00
- +
250mg
95%
in stock  
$631.00   $442.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA008TEI
Chemical Name:
6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine
CAS Number:
1062368-24-4
Molecular Formula:
C25H22N6
Molecular Weight:
406.4824
MDL Number:
MFCD17169988
SMILES:
N1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
Properties
Computed Properties
 
Complexity:
587  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
3  
XLogP3:
3.3  

Literature

Title: Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.

Journal: Journal of medicinal chemistry 20141009

Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.

Journal: Bioorganic & medicinal chemistry letters 20130801

Title: Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.

Journal: Bioorganic & medicinal chemistry letters 20130601

Title: ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells.

Journal: Cancer research 20130115

Title: BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.

Journal: PloS one 20130101

Title: Extraocular ectoderm triggers dorsal retinal fate during optic vesicle evagination in zebrafish.

Journal: Developmental biology 20121101

Title: Transient downregulation of Bmp signalling induces extra limbs in vertebrates.

Journal: Development (Cambridge, England) 20120701

Title: Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.

Journal: Molecular cancer research : MCR 20120601

Title: Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology 20120301

Title: Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology 20120201

Title: The specificities of small molecule inhibitors of the TGFß and BMP pathways.

Journal: Cellular signalling 20111101

Title: Dorsomorphin stimulates neurite outgrowth in PC12 cells via activation of a protein kinase A-dependent MEK-ERK1/2 signaling pathway.

Journal: Genes to cells : devoted to molecular & cellular mechanisms 20111101

Title: Application of small organic molecules reveals cooperative TGFβ and BMP regulation of mesothelial cell behaviors.

Journal: ACS chemical biology 20110916

Title: Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells.

Journal: The international journal of biochemistry & cell biology 20101101

Title: [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].

Journal: Clinical calcium 20101001

Title: Intersegmental vessel formation in zebrafish: requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists.

Journal: British journal of pharmacology 20100901

Title: Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20080801

Title: Yu PB, et al. BMP type I receptor inhibition reduces heterotopic [corrected ossification. Nat Med, 2008, 14(12), 1363-1369.

Title: Lee YC, et al. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res, 2011, 71(15), 5194-5203.

Title: Yang L, et al. UK-92480 increases connexin 40 in smooth muscle cells through activation of BMP pathways in pulmonary arterial hypertension. Int J Clin Exp Pathol. 2014 Jul 15;7(8):4674-84.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1062368-24-4 Molecular Formula|1062368-24-4 MDL|1062368-24-4 SMILES|1062368-24-4 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine